Tumour necrosis [alpha]-blocking agent (Etanercept): A triple blind randomised controlled trial of its use in treatment of sciatica.

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	74-77
Journal	Journal of Spinal Disorders and Techniques
Volume	23
Issue number	1
DOIs	https://doi.org/10.1097/BSD.0b013e31819afdc4
Publication status	Published - 1 Feb 2010

Access to Document

@article{971c629aa41742569353cf1774adea60,

title = "Tumour necrosis [alpha]-blocking agent (Etanercept): A triple blind randomised controlled trial of its use in treatment of sciatica.",

author = "T. Okoro and S. Tafazal and S. Longworth and P. Sell",

year = "2010",

month = feb,

day = "1",

doi = "10.1097/BSD.0b013e31819afdc4",

language = "English",

volume = "23",

pages = "74--77",

journal = "Journal of Spinal Disorders and Techniques",

issn = "0301-620X",

publisher = "British Editorial Society of Bone and Joint Surgery",

number = "1",

}

TY - JOUR

T1 - Tumour necrosis [alpha]-blocking agent (Etanercept): A triple blind randomised controlled trial of its use in treatment of sciatica.

AU - Okoro, T.

AU - Tafazal, S.

AU - Longworth, S.

AU - Sell, P.

PY - 2010/2/1

Y1 - 2010/2/1

U2 - 10.1097/BSD.0b013e31819afdc4

DO - 10.1097/BSD.0b013e31819afdc4

M3 - Article

SN - 0301-620X

VL - 23

SP - 74

EP - 77

JO - Journal of Spinal Disorders and Techniques

JF - Journal of Spinal Disorders and Techniques

IS - 1

ER -